Back to Top

Informing, inspiring, and advancing global innovation to support a healthy, sustainable future

For Immediate Release

Neonatal Screening and Early Treatment Recommended for Congenital Hypothyroidism

Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com

New Rochelle, NY, March 24, 2021—New evidence-based guidelines support global neonatal screening for congenital hypothyroidism (CH). These guidelines, endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology, are published in the peer-reviewed journal Thyroid®, the official journal of the American Thyroid Association® (ATA®). Click here to read the guidelines now

An initiative was launched to update the practice guidelines for the diagnosis and management of CH based on the latest evidence. The consensus guidelines update is intended to optimize the detection, diagnosis, treatment, and follow-up of children with all forms of CH.

“This update of the consensus guidelines on CH recommends worldwide neonatal screening and appropriate diagnostic — including genetics — to assess the cause of both primary and central hypothyroidism,” stated Paul van Trotsenburg, MD, PhD, University of Amsterdam, and coauthors. “The expert panel recommends the immediate start of correctly dosed LT4 treatment, and frequent follow-up including laboratory testing and dose adjustments to keep thyroid levels in their target ranges, timely assessments of the need to continue treatment, attention for neurodevelopmental and neurosensory function and, if necessary, consulting other health professions, and education of the child and family about CH.”

“This consensus guideline for the optimal screening and management of congenital hypothyroidism is an important publication that will have a global impact and hopefully lead to improved patient outcomes,” says Electron Kebebew, MD, FACS, Editor-in-Chief of Thyroid, Professor of Surgery, Chief, Division of General Surgery, Harry A. Oberhelman and Mark L. Welton Professor, Stanford University School of Medicine (Stanford, CA).
 
About the Journal
Thyroid, the official journal of the American Thyroid Association, is an authoritative peer-reviewed journal published monthly online with open access options and in print. The Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed on the Thyroid website. The complete Thyroid Journal Program includes the highly valued abstract and commentary publication Clinical Thyroidology®, led by Editor-in-Chief Angela Leung, MD and published monthly, and the groundbreaking videojournal companion VideoEndocrinology, led by Editor William Barry Inabnet, III, MD and published quarterly. Complete tables of content and sample issues may be viewed on the Thyroid website.
 
About the American Thyroid Association®
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,800 members from 43 countries around the world. Celebrating its 98th anniversary, the ATA delivers its mission — transforming thyroid care through clinical excellence, education, scientific discovery, and advocacy in a collaborative community — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; research grant programs for young investigators, biennial clinical and research symposia; support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet.
 
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. A complete list of the firm’s more than 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com